Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Covington
UBS
Express Scripts
Harvard Business School
McKesson
Queensland Health
QuintilesIMS
US Department of Justice
Citi

Generated: February 19, 2018

DrugPatentWatch Database Preview

Reserpine - Generic Drug Details

« Back to Dashboard

What are the generic sources for reserpine and what is the scope of reserpine freedom to operate?

Reserpine
is the generic ingredient in thirteen branded drugs marketed by Novartis, Lilly, Bowman Pharms, Bristol Myers Squibb, Barr, Bell Pharma, Bundy, Cycle Pharms Ltd, Elkins Sinn, Everylife, Halsey, Hikma Intl Pharms, Impax Labs, Ivax Sub Teva Pharms, Marshall Pharma, Mk Labs, Mylan, Pharmavite, Purepac Pharm, Pvt Form, Rexall, Sandoz, Solvay, Tablicaps, Teva, Valeant Pharm Intl, Watson Labs, Whiteworth Town Plsn, Lannett, Panray, Vale, Vitarine, Sanofi Aventis Us, and Schering, and is included in forty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for reserpine.
Medical Subject Heading (MeSH) Categories for reserpine

US Patents and Regulatory Information for reserpine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Purepac Pharm RESERPINE reserpine TABLET;ORAL 080753-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Halsey RESERPINE reserpine TABLET;ORAL 080457-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb RAU-SED reserpine TABLET;ORAL 009357-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Valeant Pharm Intl RESERPINE reserpine TABLET;ORAL 009667-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mk Labs RESERPINE reserpine TABLET;ORAL 080525-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Everylife RESERPINE reserpine TABLET;ORAL 010441-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb RAU-SED reserpine TABLET;ORAL 009357-008 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis SERPASIL reserpine TABLET;ORAL 009115-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs RESERPINE reserpine TABLET;ORAL 080679-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pvt Form RESERPINE reserpine TABLET;ORAL 080582-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Mallinckrodt
Teva
Healthtrust
US Army
Johnson and Johnson
Merck
Moodys
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot